2279 - Medical Records: Data Protection (Answered)

Mr Laurence Robertson
To ask the Secretary of State for Health, what estimate he has made of the number of people who have had their personal medical data shared despite registering to opt-out; and if he will make a statement.

George Freeman

2138 - Diabetes (Answered)

Luciana Berger
To ask the Secretary of State for Health, what discussions he has had with NICE on updated draft clinical guidelines by NICE for the management of Type 1 and Type 2 diabetes in adults; what representations he has received on those guidelines; and if he will make a statement.

George Freeman

1825 - Cancer: Medical Treatments (Answered)

Mr Gregory Campbell
To ask the Secretary of State for Health, if he will take steps to expedite the provision through the NHS of immunotherapy treatments for cancer; and if he will make a statement.

George Freeman

1602 - Health: Research (Answered)

Stephen McPartland
To ask the Secretary of State for Business, Innovation and Skills, what steps his Department is taking to encourage UK-based pharmaceutical companies to increase their contribution to global health research and development.

George Freeman

The UK life sciences sector, which includes pharmaceuticals, is one of the most productive in the world. The pharmaceuticals sector also remains the largest contributor to UK research and development, accounting for 22% of the total spend in 2013.

1401 - Bladder Cancer: Vaccination (Answered)

Mr Iain Wright
To ask the Secretary of State for Health, what steps he has taken to increase the supply of the BCG vaccine for the treatment of patients affected by bladder cancer; and if he will make a statement.

George Freeman

1281 - Clinical Priorities Advisory Group: Meetings (Answered)

Greg Mulholland
To ask the Secretary of State for Health, when NHS England's Clinical Priorities Advisory Group will meet in (a) 2015 and (b) 2016.

George Freeman

NHS England has advised that the Clinical Priorities Advisory Group (CPAG) normally meets on the first Tuesday of every month. However, for June 2015, there will be a two-day meeting on prioritisation which is scheduled to take place today and tomorrow.

The scheduled dates for 2015 are as follows:

3 February 2015

3 March 2015

7 April 2015

2071 - National Institute for Health and Care Excellence: Publications (Answered)

Greg Mulholland
To ask the Secretary of State for Health, whether it is standard practice for NICE to delay publication of draft guidance for technology appraisals as a result of pre-election purdah.

George Freeman

2068 - Diseases (Answered)

Greg Mulholland
To ask the Secretary of State for Health, what NHS England's definition is of an ultra-rare disease.

George Freeman

In the United Kingdom, the term “ultra-rare disease” is generally used to describe a condition that affects fewer than 500 people, although this is not a formal or legal definition. This equates to a prevalence of about 1 person in 100,000.

2067 - Diseases (Answered)

Greg Mulholland
To ask the Secretary of State for Health, what estimate he has made of the number of known conditions that meet NHS England's definition of an ultra-rare disease; and how many people in England are known to have been diagnosed with such diseases.

George Freeman

In the United Kingdom, the term “ultra-rare disease” is generally used to describe a condition that affects fewer than 500 people, although this is not a formal or legal definition. This equates to a prevalence of about 1 person in 100,000.

1155 - Statins: Parkinson's Disease (Answered)

David Simpson
To ask the Secretary of State for Health, if he plans to commission research into the relationship between statin use and the risk of developing Parkinson's disease.

George Freeman

Pages